Japanese researchers have discovered that NT-proBNP, a biomarker used to detect heart failure, may also predict risk of progressive CKD as well as cardiac risk in patients with Type 2 diabetes. The study followed diabetic patients with stage 1 or stage 2 CKD for 5 years and found that those with a higher baseline of … Continue reading Cardiac Biomarker May Predict Risk of Progressive CKD in Type 2 Diabetics
Skip to content
UKRO – University Kidney Research Organization
Together We Build a Kidney